IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 45,969,604
- Share change
- +1,252,652
- Total reported value
- $835,255,954
- Put/Call ratio
- 0.16%
- Price per share
- $18.17
- Number of holders
- 117
- Value change
- +$24,122,546
- Number of buys
- 73
- Number of sells
- 36
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Logos Global Management LP |
13F
|
Company |
4.7%
|
4,135,000
|
$61,694,000 | — | 30 Sep 2022 | |
| Avidity Partners Management LP |
13F
|
Company |
4.2%
|
3,715,400
|
$55,434,000 | — | 30 Sep 2022 | |
| BVF INC/IL |
13F
|
Company |
3.8%
|
3,294,859
|
$49,159,000 | — | 30 Sep 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
3.3%
|
2,862,091
|
$42,702,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3%
|
2,675,556
|
$39,919,000 | — | 30 Sep 2022 | |
| Canaan Partners X LLC |
13F
|
Company |
3%
|
2,660,713
|
$39,698,000 | — | 30 Sep 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
2.5%
|
2,202,812
|
$32,866,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
1,924,600
|
$28,715,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
1,900,381
|
$28,354,000 | — | 30 Sep 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.1%
|
1,858,877
|
$27,735,000 | — | 30 Sep 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.1%
|
1,850,094
|
$27,603,000 | — | 30 Sep 2022 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2%
|
1,743,628
|
$26,015,000 | — | 30 Sep 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.9%
|
1,668,355
|
$24,892,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.4%
|
1,254,688
|
$18,720,000 | — | 30 Sep 2022 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.4%
|
1,196,298
|
$17,849,000 | — | 30 Sep 2022 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
1.2%
|
1,011,467
|
$15,091,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
0.88%
|
773,665
|
$11,543,000 | — | 30 Sep 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.78%
|
681,177
|
$10,163,000 | — | 30 Sep 2022 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.75%
|
654,756
|
$9,769,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
626,855
|
$9,352,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.68%
|
595,332
|
$8,881,000 | — | 30 Sep 2022 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.61%
|
538,561
|
$8,035,000 | — | 30 Sep 2022 | |
| AXA S.A. |
13F
|
Company |
0.49%
|
429,118
|
$6,402,441 | — | 30 Sep 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.48%
|
418,320
|
$6,241,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.36%
|
320,508
|
$4,782,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.3%
|
266,816
|
$3,981,000 | — | 30 Sep 2022 | |
| S.c.a. Candriam |
13F
|
Individual |
0.29%
|
255,298
|
$3,809,000 | — | 30 Sep 2022 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.29%
|
253,480
|
$3,782,000 | — | 30 Sep 2022 | |
| Michael P. Dillon |
3/4/5
|
SVP, Chief Scientific Officer |
—
mixed-class rows
|
102,226
mixed-class rows
|
$3,311,116 | — | 04 Oct 2021 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.2%
|
175,000
|
$2,611,000 | — | 30 Sep 2022 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.19%
|
169,080
|
$2,523,000 | — | 30 Sep 2022 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.19%
|
165,200
|
$2,464,000 | — | 30 Sep 2022 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.15%
|
133,185
|
$1,987,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
121,009
|
$1,805,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.13%
|
112,138
|
$1,673,000 | — | 30 Sep 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.13%
|
112,119
|
$1,673,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
111,721
|
$1,667,000 | — | 30 Sep 2022 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.12%
|
109,000
|
$1,625,000 | — | 30 Sep 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.12%
|
105,510
|
$1,574,000 | — | 30 Sep 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.11%
|
100,171
|
$1,495,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
91,704
|
$1,369,000 | — | 30 Sep 2022 | |
| Swiss National Bank |
13F
|
Company |
0.1%
|
90,700
|
$1,353,000 | — | 30 Sep 2022 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.09%
|
80,112
|
$1,195,000 | — | 30 Sep 2022 | |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
|
Company |
0.08%
|
74,269
|
$1,108,000 | — | 30 Sep 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
70,608
|
$1,053,000 | — | 30 Sep 2022 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.08%
|
70,000
|
$1,044,000 | — | 30 Sep 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.07%
|
62,565
|
$933,000 | — | 30 Sep 2022 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.07%
|
60,000
|
$895,000 | — | 30 Sep 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
53,678
|
$801,000 | — | 30 Sep 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.06%
|
53,341
|
$795,848 | — | 30 Sep 2022 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q4 2022
As of 31 Dec 2022,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,969,604 shares.
The largest 10 holders included
Logos Global Management LP, Avidity Partners Management LP, BlackRock Inc., FEDERATED HERMES, INC., Canaan Partners X LLC, STATE STREET CORP, VANGUARD GROUP INC, BVF INC/IL, Boxer Capital, LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
117
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
111
Q4 2022 holders
117
Holder diff
6
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.